Loading
Latest filing published 11 May 2026 for LAKEFRONT BIOTHERAPEUTICS. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Blakeslee Fred discloses dealings in Lakefront Biotherapeutics to FSMA. We count 4 filings; the first trade dates from 9 December 2025 and the latest from 20 March 2026.
No open-market sale appears; the market trades are 4 purchases. The totals do not cover 4 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 4 purchases and no sales.
The record was last updated on 11 May 2026 with an open-market purchase in Lakefront Biotherapeutics. The median gap between a trade and its publication by FSMA is 50 days. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from FSMA disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations